Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy

NCT04339634 is registered in ClinicalTrials.gov with Tabula Rasa HealthCare as lead sponsor.

NCT NCT04339634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04339634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy
Lead sponsor
Tabula Rasa HealthCare
Phase
Observational
Overall status
Completed
Start date
April 2, 2020
Completion date
January 30, 2023
Enrollment
12,873 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event, covid, drug effect, drug interaction